title: European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
abstract: The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.
authors.affiliation: Mucosal Immunology Unit, Kings College at Guy's Hospital, Guy's Tower, London SE1 9RT, UK.
authors.forename: Thomas
authors.initials: T
authors.lastname: Lehner
authors.forename: Michael
authors.initials: M
authors.lastname: Hoelscher
authors.forename: Mario
authors.initials: M
authors.lastname: Clerici
authors.forename: Frances
authors.initials: F
authors.lastname: Gotch
authors.forename: Louise
authors.initials: L
authors.lastname: Pedneault
authors.forename: Jim
authors.initials: J
authors.lastname: Tartaglia
authors.forename: Clive
authors.initials: C
authors.lastname: Gray
authors.forename: Jiri
authors.initials: J
authors.lastname: Mestecky
authors.forename: Quentin
authors.initials: Q
authors.lastname: Sattentau
authors.forename: Janneke
authors.initials: J
authors.lastname: van de Wijgert
authors.forename: Coumba
authors.initials: C
authors.lastname: Toure
authors.forename: Saladin
authors.initials: S
authors.lastname: Osmanov
authors.forename: Reinold E
authors.initials: RE
authors.lastname: Schmidt
authors.forename: Patrice
authors.initials: P
authors.lastname: Debre
authors.forename: Manuel
authors.initials: M
authors.lastname: Romaris
authors.forename: Arnd
authors.initials: A
authors.lastname: Hoeveler
authors.forename: Simonetta
authors.initials: S
authors.lastname: Di Fabio
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000592:standards*; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003906:Developing Countries; D005062:European Union; D006678:HIV / Q000254:growth & development / Q000276:immunology; D006287:Health Planning Guidelines; D006801:Humans; D012449:Safety
chemical_list: D016915:AIDS Vaccines